European journal of cancer (Oxford, England : 1990)1996Vol. 32App. -
367
ec1996europeanearly
Abstract
The aim of this multicentre randomised trial was to determine whether it was possible to predict grampositive bacteraemia, and whether the empirical use of vancomycin would lead to reduced morbidity and mortality. 35 of 113 patients (31%; confidence interval, CI 8.5), who presented with a skin or so …